{
    "2019-02-15": [
        [
            {
                "time": "",
                "original_text": "基金调研:云映资产调研康泰生物 招商银行访江苏国信",
                "features": {
                    "keywords": [
                        "基金调研",
                        "云映资产",
                        "康泰生物",
                        "招商银行",
                        "江苏国信"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：23价肺炎疫苗预计年中上市销售",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "23价肺炎疫苗",
                        "上市",
                        "销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}